{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fpsychedelic-spotlight.simplecast.com%2Fepisodes%2Fjosh-bartch-oe4AjoVp","width":444,"version":"1.0","type":"rich","title":"Josh Bartch, Mydecine Innovations Group","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/bebecc7d-bab7-47e7-be66-437a184e067d/a59b409f-9e99-451f-abae-6736d30441ea/simplecast-cover.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/b9925371-ff88-4f6e-b080-8aab4ed2b542\" height=\"200\" width=\"100%\" title=\"Josh Bartch, Mydecine Innovations Group\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Global Trac Solutions, Inc. CEO, David Flores sits down to speak with Co-Founder & CEO, of Mydecine Innovations Group, Josh Bartch.\n\nDavid and Josh take some time to talk about Mydecine as a company, and, what path they're taking in 2021, the passing of Measure 109 in Oregon, aiding veterans through psychedelics, and more."}